Characterization of Structure and Function of ZS-9, α K+ Selective Ion Trap

被引:146
作者
Stavros, Fiona [1 ]
Yang, Alex [2 ]
Leon, Alejandro [1 ]
Nuttall, Mark [1 ]
Rasmussen, Henrik S. [1 ]
机构
[1] ZS Pharma Inc, Coppell, TX 75019 USA
[2] Xelay Acumen Inc, Belmont, CA USA
关键词
HEART-FAILURE; HYPERKALEMIA; POTASSIUM; SPIRONOLACTONE; ZIRCONIUM; MORTALITY; RESIN;
D O I
10.1371/journal.pone.0114686
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Hyperkalemia, a condition in which serum potassium ions (K+) exceed 5.0 mmol/L, is a common electrolyte disorder associated with substantial morbidity. Current methods of managing hyperkalemia, including organic polymer resins such as sodium polystyrene sulfonate (SPS), are poorly tolerated and/or not effective. Sodium zirconium cyclosilicate (ZS-9) is under clinical development as an orally administered, non-absorbed, novel, inorganic microporous zirconium silicate compound that selectively removes excess K+ in vivo. The development, structure and ion exchange properties of ZS-9 and its hypothesized mechanism of action are described. Based on calculation of the interatomic distances between the atoms forming the ZS-9 micropores, the size of the pore opening was determined to be similar to 3 angstrom (similar to diameter of unhydrated K+). Unlike nonspecific organic polymer resins like SPS, the ZS-9 K+ exchange capacity (KEC) was unaffected by the presence of calcium (Ca2+) or magnesium ions (Mg2+) and showed. 25-fold selectivity for K+ over either Ca2+ or Mg2+. Conversely, the selectivity of SPS for K+ was only 0.2-0.3 times its selectivity for Ca2+ or Mg2+ in mixed ionic media. It is hypothesized that the high K+ specificity of ZS-9 is attributable to the chemical composition and diameter of the micropores, which possibly act in an analogous manner to the selectivity filter utilized by physiologic K+ channels. This hypothesized mechanism of action is supported by the multi-ion exchange studies. The effect of pH on the KEC of ZS-9 was tested in different media buffered to mimic different portions of the human gastrointestinal tract. Rapid K+ uptake was observed within 5 minutes - mainly in the simulated small intestinal and large intestinal fluids, an effect that was sustained for up to 1 hour. If approved, ZS-9 will represent a novel, first-in-class therapy for hyperkalemia with improved capacity, selectivity, and speed for entrapping K+ when compared to currently available options.
引用
收藏
页数:12
相关论文
共 34 条
[1]   Review: Understanding sorbent dialysis systems [J].
Agar, John W. M. .
NEPHROLOGY, 2010, 15 (04) :406-411
[2]  
[Anonymous], 2014, SUMM REP DET ZIRC SI
[3]  
[Anonymous], DIFFUSION TRANSPORT
[4]  
Ash S, 2014, KIDNEY INT IN PRESS
[5]   Sorbents in Treatment of Uremia: A Short History and a Great Future [J].
Ash, Stephen R. .
SEMINARS IN DIALYSIS, 2009, 22 (06) :615-622
[6]  
Bem D, 2001, ASAIO J, V47, P151
[7]  
Bem D, 1999, Patent No. [005891417A, 005891417]
[8]  
Bem D, 1999, Patent No. [005888472A, 005888472]
[9]  
Bem DS, 1999, MATER RES SOC SYMP P, V549, P73
[10]  
BERLYNE GM, 1966, LANCET, V1, P169